TCL Archive Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed October 8, 1976
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive NCAB to Get NCI Bypass Budget May 13; DeVita Tells Centers That Is Where “Our Philosophy Can Be Found” May 3, 1985
